Intracellular Property Plant And Equipment Net vs Cash Analysis
ITCI Stock | USD 84.99 0.70 0.82% |
Intracellular financial indicator trend analysis is infinitely more than just investigating Intracellular Th recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Intracellular Th is a good investment. Please check the relationship between Intracellular Property Plant And Equipment Net and its Cash accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intracellular Th. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Property Plant And Equipment Net vs Cash
Property Plant And Equipment Net vs Cash Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Intracellular Th Property Plant And Equipment Net account and Cash. At this time, the significance of the direction appears to have strong relationship.
The correlation between Intracellular's Property Plant And Equipment Net and Cash is 0.69. Overlapping area represents the amount of variation of Property Plant And Equipment Net that can explain the historical movement of Cash in the same time period over historical financial statements of Intracellular Th, assuming nothing else is changed. The correlation between historical values of Intracellular's Property Plant And Equipment Net and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Property Plant And Equipment Net of Intracellular Th are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Property Plant And Equipment Net i.e., Intracellular's Property Plant And Equipment Net and Cash go up and down completely randomly.
Correlation Coefficient | 0.69 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Cash
Cash refers to the most liquid asset of Intracellular Th, which is listed under current asset account on Intracellular Th balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Intracellular customers. The amounts must be unrestricted with restricted cash listed in a different Intracellular account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.Most indicators from Intracellular's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Intracellular Th current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intracellular Th. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. As of now, Intracellular's Selling General Administrative is increasing as compared to previous years. The Intracellular's current Tax Provision is estimated to increase to about 667.8 K, while Issuance Of Capital Stock is projected to decrease to 0.00.
2021 | 2022 | 2023 | 2024 (projected) | Net Interest Income | 1.6M | 7.4M | 20.3M | 21.4M | Interest Income | 1.6M | 7.4M | 20.3M | 21.4M |
Intracellular fundamental ratios Correlations
Click cells to compare fundamentals
Intracellular Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Intracellular fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 251.2M | 717.3M | 489.9M | 754.8M | 728.3M | 410.9M | |
Other Current Liab | 25.6M | 25.8M | 37.9M | 63.7M | 108.5M | 113.9M | |
Total Current Liabilities | 36.2M | 36.9M | 53.4M | 83.2M | 123.5M | 129.7M | |
Total Stockholder Equity | 195.0M | 656.9M | 417.9M | 656.1M | 591.4M | 366.2M | |
Accounts Payable | 7.4M | 5.5M | 8.7M | 10.4M | 11.5M | 6.4M | |
Cash | 107.6M | 60.0M | 92.4M | 148.6M | 147.8M | 74.0M | |
Other Assets | 608.1K | 350.7K | 86.1K | 86K | 98.9K | 94.0K | |
Common Stock Shares Outstanding | 55.2M | 70.4M | 81.3M | 94.0M | 95.9M | 55.1M | |
Short Term Investments | 116.4M | 597.4M | 320.0M | 443.3M | 350.2M | 287.1M | |
Other Current Assets | 6.3M | 15.6M | 26.8M | 46.9M | 42.4M | 44.6M | |
Total Liab | 56.2M | 60.5M | 72.0M | 98.7M | 136.9M | 143.7M | |
Common Stock | 5.6K | 8.0K | 8.2K | 9K | 10K | 6.6K | |
Property Plant Equipment | 2.3M | 2.0M | 22.6M | 1.9M | 2.2M | 3.0M | |
Net Tangible Assets | 195.0M | 656.9M | 417.9M | 656.1M | 754.5M | 792.2M | |
Property Plant And Equipment Net | 20.5M | 26.3M | 22.6M | 16.7M | 14.6M | 9.6M | |
Net Debt | (84.5M) | (30.9M) | (67.0M) | (128.6M) | (130.8M) | (124.3M) | |
Retained Earnings | (710.1M) | (937.1M) | (1.2B) | (1.5B) | (1.6B) | (1.5B) | |
Non Current Assets Total | 20.9M | 26.4M | 22.6M | 16.8M | 60.5M | 63.5M | |
Cash And Short Term Investments | 224.0M | 657.4M | 412.3M | 591.9M | 497.9M | 388.7M | |
Common Stock Total Equity | 5.6K | 8.0K | 8.2K | 9K | 10.4K | 5.5K | |
Retained Earnings Total Equity | (710.1M) | (937.1M) | (1.2B) | (1.5B) | (1.3B) | (1.3B) | |
Liabilities And Stockholders Equity | 251.2M | 717.3M | 489.9M | 754.8M | 728.3M | 443.0M | |
Non Current Liabilities Total | 20.0M | 23.6M | 18.7M | 15.5M | 13.3M | 10.0M | |
Capital Surpluse | 905.0M | 1.6B | 1.6B | 2.1B | 2.5B | 2.6B | |
Other Stockholder Equity | 905.0M | 1.6B | 1.6B | 2.1B | 2.2B | 2.3B | |
Property Plant And Equipment Gross | 20.5M | 26.3M | 1.8M | 1.9M | 14.6M | 15.3M | |
Total Current Assets | 230.3M | 690.9M | 467.3M | 738.0M | 667.8M | 428.9M | |
Accumulated Other Comprehensive Income | 128.3K | 480.6K | (363.7K) | (4.2M) | 104K | 109.2K | |
Net Invested Capital | 195.0M | 656.9M | 417.9M | 656.1M | 591.4M | 516.9M | |
Net Working Capital | 194.1M | 654.1M | 413.9M | 654.7M | 544.3M | 508.4M | |
Capital Stock | 5.6K | 8.0K | 8.2K | 9K | 10K | 8.5K |
Currently Active Assets on Macroaxis
When determining whether Intracellular Th offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Intracellular's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Intracellular Th Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Intracellular Th Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Intracellular Th. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intracellular. If investors know Intracellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intracellular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.87) | Revenue Per Share 6.096 | Quarterly Revenue Growth 0.39 | Return On Assets (0.07) | Return On Equity (0.1) |
The market value of Intracellular Th is measured differently than its book value, which is the value of Intracellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intracellular's value that differs from its market value or its book value, called intrinsic value, which is Intracellular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intracellular's market value can be influenced by many factors that don't directly affect Intracellular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intracellular's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intracellular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intracellular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.